Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04061148 · ClinicalTrials.gov registry record · NA

Near Infrared Spectroscopy (NIRS) for Assessment of Depression

A NA study of Major Depressive Disorder, sponsored by University of California, San Francisco.

Recruiting
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT04061148 is a NA study of Major Depressive Disorder that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 90 participants, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04061148, a NA study of Major Depressive Disorder, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

Develop a NIRSIT testing protocol that can be administered in the diagnostic setting and reliably distinguishes the symptoms and severity of depression, with the help of repeated measure (up to five visits per subject) comparison of patients being treated for Major Depressive Disorder with control, non-depressed subjects.

Conditions Studied

Interventions

  • DEVICE NIRSIT

Study Locations (1)

California

  • San Francisco Veterans Affairs Medical Center - San Francisco

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2019-01-04
Est. Completion 2027-12-30
Phase NA

What the Registry Record Tells You About NCT04061148

The ClinicalTrials.gov registry entry for NCT04061148 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (76% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Major Depressive Disorder appearing as the primary indexed condition, and to 1 intervention - of which NIRSIT is the first listed.

NCT04061148 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04061148 about?

NCT04061148 is a clinical study titled "Near Infrared Spectroscopy (NIRS) for Assessment of Depression". Develop a NIRSIT testing protocol that can be administered in the diagnostic setting and reliably distinguishes the symptoms and severity of depression, with the help of repeated measure (up to five visits per subject) comparison of patients being treated for Major Depressive Disorder with control, ...

What is the current status of trial NCT04061148?

This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2019-01-04. Estimated completion is 2027-12-30.

What conditions does trial NCT04061148 study?

This clinical trial studies the following conditions: Major Depressive Disorder.

What interventions are being tested in trial NCT04061148?

The interventions under investigation include: NIRSIT (DEVICE).

Who is sponsoring clinical trial NCT04061148?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04061148 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Major Depressive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.